Aumed, a.s., Komořanská 326/63, 143 14 Praha - Modřany, Česká republika

+420 603 587 701 English

Achievements in current grants

research-and-development

The project of innovative vaccine against whooping cough is in the terminal phase. The priority is the research and development of whole-cell pertussis vaccine, which is to be characterized by reduced reactogenicity. This goal has already been achieved by two independent approach – first is based on genetic manipulation and second is based on innovative technological processes for the preparation of the active substance. We are currently finalizing the documentation.

 

The Transfer Factor project is also very successfully solved. In cooperation with the Faculty of Pharmacy of the Charles University in Hradec Králové, a tablet construction with a satisfactory composition and suitable physical properties has been developed. Orientation preclinical tests are currently underway and the manufacturing technology is modified to be applicable in potential commercial drug production.

MORE ARTICLES

AUMED, a.s. successfully completed the 1st stage of the project entitled “Transferfaktor TFI – Medicinal product”

29. 11. 2022

AUMED, a.s. successfully completed the 1st stage of the project entitled “Transferfaktor TFI – Medicinal product”, registration number CZ.01.1.02/0.0/0.0/20_318/0026008. As…

AUMED, a.s. presented phage research at the Phages 2022 conference in Oxford

26. 09. 2022

AUMED participated in the 12th annual bacteriophage conference in Oxford, which is the only European phage conference with such a…

AUMED a.s. founded a new company AUMED Immunology a.s.

19. 09. 2022

AUMED a.s. founded a new company AUMED Immunology a.s.. AUMED, a.s. is the sole shareholder of the newly formed company….

Research projects of Aumed, a.s. are financed by the European Structural Funds:
Research and development of a new pertussis vaccine
Transfer factor — research and development of a new medical form
Production of diagnostic kit for covid-19 on the lamp principle
TFI Transfer Factor – Medicine

and with financial support from the state budget through the Ministry of Industry and Trade in the TRIO program:
Research and development of a new oral administration of vaccine

European Union
European Regional Development Fund
OP Enterprise and Innovation for Competitiveness


Tel.: +420 603 587 701
Komořanská 326/63, 143 14 Praha - Modřany, Česká republika
(c) 2017, Aumed a.s